Herceptin and chemotherapy improves response rates without major adverse effects in H

[News]

Women with a particularly aggressive form of breast cancer seem to do better if they are treated with a combined anthracycline and taxane chemotherapy regimen before surgery, together with trastuzumab (Herceptin) before and after surgery, according to results from the largest multi-centre trial to investigate this treatment.

More... (http://www.news-medical.net/?id=37493)